GTG Genetic Technologies Limited
—Mkt Cap: —P/E: —1d ago
Genetic Technologies Limited, a molecular diagnostics company, engages in the provision of predictive genetic testing and risk assessment tools to help physicians manage people's health in the America, Canada, Europe, th…
Industry Peers
Biotechnology$128.87BUSDP/E 29.6
$94.42BUSD
$81.99BUSDP/E 19.1
$53.47BUSDP/E 32.5
$53.22BUSDP/E 31.6
$44.02BUSDP/E 17.8
$42.56BUSDP/E 66.4
$40.57BUSD
$34.45BUSDP/E 30.4
$31.32BUSDP/E 39.3
$24.59BUSD
$23.32BUSDP/E 31.7
$23.26BUSDP/E 29.8
$22.96BUSDP/E 14.0
$22.66BUSD
$21.67BUSD
$15.57BUSDP/E 19.3
$14.91BUSDP/E 17.4
$13.92BUSDP/E 14.7
$13.79BUSDP/E 33.4
Key Statistics
Company
Market Cap—
Enterprise Value36.06M USD
Revenue (TTM)—
Gross Profit-140.78K USD
Net Income (TTM)-1.01M USD
Revenue/Share—
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryBiotechnology
ISINAU000000GTG7
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-148.71
EV/Revenue—
P/S—
P/B—
EPS (TTM)-0.09
EPS (Forward)—
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-14633.10%
ROA-14633.10%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-77.43K USD
CapEx (TTM)4.89K USD
FCF Margin—
FCF Yield—
Net Debt70.34K USD
Net Debt/EBITDA-0.29
Balance Sheet
Debt/Equity0.00
Current Ratio0.08
Quick Ratio0.06
Book Value/Sh0.00 AUD
Cash/Share0.00 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateDec 14, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.145.42M
Float163.06M
Insiders89.56%
Institutions0.00%
Technical
SMA 500.0390 AUD
SMA 2000.0390 AUD
Beta0.14
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)0
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—